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ATL is an aggressive peripheral T-cell neoplasm that devel-
ops after long-term infection with HTLV-1. The develop-
ment of new treatment with ATL is desired. SIRT1, a
nicotinamide adenine dinucleotide (NAD+)-dependent
histone/protein deacetylase, plays a crucial role in various
physiological processes, such as aging and apoptosis, owing
to its ability to deacetylate numerous substrates. Here, we
assessed how SIRT1 is regulated in primary ATL cells and
leukemic cell lines. SIRT1 expression in ATL patients was
significantly higher than that in healthy controls. NCO-01
and NCO-04, novel small-molecule SIRT1 inhibitors,
induced significant growth inhibition or apoptosis in leuke-
mic cell lines, especially S1T cells, which is HTLV-1-
infected CD4+ T cells derived from an ATL patient with
no Tax expression. NCO-01 and NCO-04-induced apopto-
sis was mediated by activation of the caspase family. Lack
of SIRT1 expression also increased the apoptosis of MT-2
cells. These results suggest that SIRT1 is a crucial anti-
apoptotic molecule in ATL cells. Therefore, methods to
block the function of SIRT1 may be useful in developing
ideal therapeutic agents for leukemia, especially in patients
with ATL.
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